.png){kind=icon}
返回
Islet encapsulation
.png){kind=icon}
PRE
AI
DOI：10.1039/c8tb02020e.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
This review focuses on recent engineering advances in islet encapsulation technologies. beta-cell replacement therapy in the form of allogeneic naked islet transplantation has become an established treatment for type 1 diabetes mellitus (T1DM). However, some limitations still impact the broad applicability and long-term efficacy of the procedure, including shortage of donor islets, the need for lifelong immunosuppression, and restriction to the most vulnerable patients. Islet encapsulation promises to overcome these constraints by providing a selectively permeable barrier between host and therapeutic tissues. While tremendous progress has been made and the clearing of key translational hurdles appears to be near, many challenges need to be addressed before this technology platform can enter the clinic. Here, we summarize the research in this area and seek to identify the outstanding challenges in translating islet encapsulation technology to human patients.
Keyword:
REGULATORY T-CELLS
POLY(ETHYLENE GLYCOL) DIACRYLATE
TYPE-1 DIABETIC-PATIENT
BETA-CELLS
PANCREATIC-ISLETS
IN-VITRO
NONIMMUNOSUPPRESSED PATIENTS
MICROENCAPSULATED ISLETS
COMPOSITE MICROCAPSULES
MACROPHAGE POLARIZATION
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
5.7
论文数:
1.1W
被引数:
4.3W
机构
引用论文
Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates组合水凝胶库可以识别减轻灵长类动物异物反应的材料.png)
NATURE BIOTECHNOLOGY
OAAI
NATURE BIOTECHNOLOGYIF41.7
OAAI分享收藏Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cellsNATURE COMMUNICATIONS
OAAI
NATURE COMMUNICATIONSIF15.7
OAAI分享收藏Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetesBIOMATERIALSOAAI
BIOMATERIALSIF12.9
OAAI分享收藏
查看更多内容